Section one: Contracting authority
one.1) Name and addresses
Business Energy and Industrial Strategy
1 Victoria Street
London
SW1H0ET
Country
United Kingdom
NUTS code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
General public services
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Advance Purchase Agreement
Reference number
2611/09/2020
two.1.2) Main CPV code
- 33651600 - Vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.14) Additional information
Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments; and
(ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The services can be provided only by a particular economic operator for the following reason:
- absence of competition for technical reasons
- Additional deliveries by the original supplier
Explanation:
The award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii).
Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2020/S 227-560526
Section five. Award of contract
Contract No
2611/09/2020
Title
Advance Purchase Agreement
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 September 2021
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor
Aventis Pharma Ltd
Thames Valley Park Drive, Reading
Berkshire
RG6 1PT
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor is an SME
No
five.2.3) Name and address of the contractor
GlaxoSmithKline Biologicals S.A
Rue de l'Institut 89
Rixensart
B-1330
Country
Belgium
NUTS code
- BE - Belgium
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1
Total value of the contract/lot: £1
Section six. Complementary information
six.3) Additional information
Additional information: contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Also, given significant competition to bring to the market a successful vaccine, provision of the contract term is valuable information to competitors that may impact negotiations/future competition.
six.4) Procedures for review
six.4.1) Review body
Department of Business, Energy and Industrial Strategy
1 Victoria Street, Westminister
London
SW1H 0ET
Country
United Kingdom